跳至主要内容
临床试验/NL-OMON56966
NL-OMON56966尚未招募不适用

Evaluation of cardiac troponin dynamics as an early biomarker for anthracycline-induced cardiotoxicity - ANTROP-study

Sint Antonius Ziekenhuis0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age >= 18 years
  • - Patients that are to be treated for breast cancer in the adjuvant setting
  • with one of the following treatment schedules, in accordance with SAZ
  • o Doxorubicine and cyclofosfamide q2w for 4 cycles, followed by paclitaxel q1w
  • for 12 cycles
  • o Doxorubicine and cyclofosfamide q3w for 4 cycles, followed by paclitaxel q1w
  • - Informed consent form (ICF) signed prior to participation in the study.

排除标准

  • Patients that already started treatment in one of the above described protocols
  • are not eligible for inclusion, since a baseline sample is necessary.

研究者

相似试验